Tagged with “fostamatinib”

Trial of New Drug to Blocks Cell Changes Available at NIH Clinical Center

An oral drug that blocks activity of enzymes that change proteins in cells that leads to cancer is being tested at the National Institutes of Health.

R935788 or Fostamatinib, a protein kinase inhibitor, is in a Phase II clinical trial for patients with several types of advanced cancer, including colorectal cancer. Patients whose cancer has gotten worse on previous treatment are eligible to participate. The trial is being conducted at the NIH Clinical Center in Bethesda, Maryland. Continue reading…

Posted by Kate Murphy on July 30th, 2009
Posted in: Research & Treatment News | No Comments »
Tags: clinical trials, fostamatinib, NIH Clinical Center

Search C3

Win Tickets to the US Open Series

Make a donation to the Colorectal Cancer Coalition before Aug 5th for a chance to win tickets to the US Open Series in the following cities: Washington, DC; San Diego, CA; Cincinnati, OH; and New Haven, CT.

Donate and enter!

Good luck!

Sweepstakes ends on Thursday, August 5. Click here for official rules.

Follow C3

Join us on Facebook

Watch us on YouTube

Register to receive our free e-newsletter

Get monthly updates on colorectal cancer treatment options, research news and advocacy opportunities. We promise to not bombard you with email - just enough to keep you informed on how to fight colorectal cancer.